Bispecific antibody conjugates in therapeutics
Authors:
- Ying CaoYCYing Cao
- Laura LamLLLaura Lam
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 55 (2) , 171-197
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- Antibody humanization: a case of the ‘Emperor’s new clothes’?Immunology Today, 2000
- Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionFEBS Letters, 1999
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Treatment of B-cell lymphomas with combination of bispecific antibodies and saporinThe Lancet, 1995
- Capture of recombinant ricin A chain by a bispecific anti-RTA: anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude miceJournal of Cancer Research and Clinical Oncology, 1992
- Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal‐cell carcinoma xenografts: Relative effects of size and affinityInternational Journal of Cancer, 1991
- T cell targeting in cancer therapyCancer Immunology, Immunotherapy, 1991
- Bifunctional antibodies: concept, production and applicationsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastineCancer Immunology, Immunotherapy, 1990
- A novel strategy for producing chimeric bispecific antibodies by gene transfectionBiochemical and Biophysical Research Communications, 1989